Engineers and medical researchers at the University of Minnesota have teamed up to create a groundbreaking 3D-printed device that could someday help patients with long-term spinal cord injuries regain some function.
A 3D-printed guide, made of silicone, serves as a platform for specialized cells that are then 3D printed on top of it. The guide would be surgically implanted into the injured area of the spinal cord where it would serve as a type of “bridge” between living nerve cells above and below the area of injury. The hope is that this would help patients alleviate pain as well as regain some functions like control of muscles, bowel and bladder.
The research is published online today in Advanced Functional Materials, a peer-reviewed scientific journal.
“This is the first time anyone has been able to directly 3D print neuronal stem cells derived from adult human cells on a 3D-printed guide and have the cells differentiate into active nerve cells in the lab,” said Michael McAlpine, Ph.D., a co-author of the study and University of Minnesota Benjamin Mayhugh Associate Professor of Mechanical Engineering in the University’s College of Science and Engineering.
“This is a very exciting first step in developing a treatment to help people with spinal cord injuries,” said Ann Parr, M.D., Ph.D., a co-author of the study and University of Minnesota Medical School Assistant Professor in the Department of Neurosurgery and Stem Cell Institute. “Currently, there aren’t any good, precise treatments for those with long-term spinal cord injuries.”
There are currently about 285,000 people in the United States who suffer from spinal cord injuries, with about 17,000 new spinal cord injuries nationwide each year.
In this new process developed at the University of Minnesota over the last two years, researchers start with any kind of cell from an adult, such as a skin cell or blood cell. Using new bioengineering techniques, the medical researchers are able to reprogram the cells into neuronal stem cells. The engineers print these cells onto a silicone guide using a unique 3D-printing technology in which the same 3D printer is used to print both the guide and the cells. The guide keeps the cells alive and allows them to change into neurons. The team developed a prototype guide that would be surgically implanted into the damaged part of the spinal cord and help connect living cells on each side of the injury.
“Everything came together at the right time,” Parr said. “We were able to use the latest cell bioengineering techniques developed in just the last few years and combine that with cutting-edge 3D-printing techniques.”
Even with the latest technology, developing the prototype guides wasn’t easy.
“3D printing such delicate cells was very difficult,” McAlpine said. “The hard part is keeping the cells happy and alive. We tested several different recipes in the printing process. The fact that we were able to keep about 75 percent of the cells alive during the 3D-printing process and then have them turn into healthy neurons is pretty amazing.”
If the next steps are successful, the payoff for this research could be life-changing for those who suffer from spinal cord injuries.
“We’ve found that relaying any signals across the injury could improve functions for the patients,” Parr said. “There’s a perception that people with spinal cord injuries will only be happy if they can walk again. In reality, most want simple things like bladder control or to be able to stop uncontrollable movements of their legs. These simple improvements in function could greatly improve their lives.”
The Latest on: Spinal cord injury
via Google News
The Latest on: Spinal cord injury
- Ministry OKs 1st iPS cell therapy trial for spinal cord injuries on February 19, 2019 at 2:00 am
Four patients to be selected for the trial slated to start in autumn will have been diagnosed between two to four weeks beforehand as totally paralyzed with no mobility and sensory functions, the most ... […]
- Japan Approves iPS Cell Therapy Trial for Spinal Cord Injury on February 18, 2019 at 1:09 pm
The Japanese government’s health ministry has given the go-ahead for a trial of human induced pluripotent stem cells to treat spinal cord injury, Reuters reports today (February 18). Researchers at Ke... […]
- Japan approves test of iPS cells for treating spinal injuries on February 18, 2019 at 5:47 am
The Keio University team headed by professors Hideyuki Okano and Masaya Nakamura will seek four patients, aged 18 or older, who have lost mobility and sensory functions due to a spinal cord injury sus... […]
- Establishing the inter-rater reliability of spinal cord damage manual measurement using magnetic resonance imaging on February 18, 2019 at 5:01 am
... the inter-rater reliability in the quantitative evaluation of spinal cord damage following cervical incomplete spinal cord injury (SCI) utilizing magnetic resonance imaging (MRI). MRI was used to ... […]
- Spinal cord stimulator device shows promise in Minneapolis study on February 16, 2019 at 5:00 am
Numerous questions remain, but the findings should lead to an effort to develop strategies "to maximize recovery in all participants with chronic SCI," or spinal-cord injury, the report says. The stud... […]
- Researchers test new way to restore bladder control after spinal cord injury on February 15, 2019 at 6:29 pm
Twenty nine-year-old Hinesh Patel broke his neck and damaged his spine when he fell off a balcony last year. The M.D., Ph.D. student has traveled the world and was super active. He's getting back ... […]
- RDD Pharma Receives Fast Track Designation from FDA for RDD-0315 for Treatment of Fecal Incontinence in Spinal Cord Injury Patients on February 14, 2019 at 3:00 am
NEW YORK, Feb. 14, 2019 /PRNewswire/ -- RDD Pharma, Inc., a specialty pharmaceutical company focused on development and commercialization of innovative therapeutics for anorectal and lower gastrointes... […]
- Spinal Cord Injury market report 2019 detailed in new research report on February 13, 2019 at 2:55 am
The Spinal Cord Injury market Reports offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Spinal Cord I... […]
- BioArctic's Product Candidate SC0806 for Treatment of Patients With Complete Spinal Cord Injury is now in Phase 2 on February 12, 2019 at 11:59 pm
STOCKHOLM, Feb. 13, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the first patient in the second panel of the Phase 1/2 study now has been treated with ... […]
via Bing News